A team led by Prof. Fabian Theis developed HADGE, a new tool that improves the accuracy and efficiency of identifying individual donors in single-cell studies. The work, recently published in Genome Biology, represents a major step forward in the…
On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.
At the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) in Leipzig, two metabolic chambers for humans have been constructed with the objective of determining the influence of obesity and other metabolic diseases on energy…
Over the next four years, Helmholtz Munich participates in a European research consortium, aiming to develop an innovative technology that could boost the regeneration of neurons in diseases that currently have limited therapeutic options. The…
A new paper published in Developmental Cell is the result of a collaboration between the Scialdone (Helmholtz Munich) and Srinivas (Oxford) groups. The two teams combined their respective experimental and computational expertise to unravel the…
The diagnosis of type 1 diabetes often comes with serious complications for families, as the autoimmune disease is frequently detected only after severe symptoms develop. Early detection of type 1 diabetes through population-wide screening offers…
Awards & Grants, Diabetes, HI-MAG,
Awards & Grants, ICB,
Awards & Grants, ING,
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: